

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of fibroblast migration (GO:0010763) | 3.83496950 |
| 2 | glucose 6-phosphate metabolic process (GO:0051156) | 3.52157234 |
| 3 | protein localization to endosome (GO:0036010) | 3.49803297 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 3.30252524 |
| 5 | plasma membrane repair (GO:0001778) | 3.18216251 |
| 6 | adenosine receptor signaling pathway (GO:0001973) | 3.16609966 |
| 7 | cellular extravasation (GO:0045123) | 3.10389152 |
| 8 | hypotonic response (GO:0006971) | 3.09446406 |
| 9 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.08498191 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.06860532 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.06860532 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.06860532 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.06860532 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 3.06860532 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.06860532 |
| 16 | positive regulation of receptor recycling (GO:0001921) | 3.06572122 |
| 17 | regulation of histone phosphorylation (GO:0033127) | 3.05220474 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.02675181 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.00955169 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.00955169 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00551169 |
| 22 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.99805320 |
| 23 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.97423422 |
| 24 | mannose metabolic process (GO:0006013) | 2.95481295 |
| 25 | skin morphogenesis (GO:0043589) | 2.88026464 |
| 26 | synaptic vesicle maturation (GO:0016188) | 2.83992575 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83916393 |
| 28 | astrocyte differentiation (GO:0048708) | 2.83378418 |
| 29 | glandular epithelial cell development (GO:0002068) | 2.81904899 |
| 30 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79248705 |
| 31 | negative regulation of anoikis (GO:2000811) | 2.79139425 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 2.78731735 |
| 33 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.78254573 |
| 34 | stress fiber assembly (GO:0043149) | 2.76549906 |
| 35 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.76490255 |
| 36 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.76438588 |
| 37 | glutamate secretion (GO:0014047) | 2.76240412 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 2.74746289 |
| 39 | wound healing, spreading of epidermal cells (GO:0035313) | 2.73516111 |
| 40 | synaptic vesicle exocytosis (GO:0016079) | 2.71262388 |
| 41 | gland morphogenesis (GO:0022612) | 2.68819739 |
| 42 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.68427274 |
| 43 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.68229670 |
| 44 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65304409 |
| 45 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.63167497 |
| 46 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.60915098 |
| 47 | cornea development in camera-type eye (GO:0061303) | 2.59240694 |
| 48 | endodermal cell differentiation (GO:0035987) | 2.56198718 |
| 49 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55308500 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 2.52113723 |
| 51 | negative regulation of norepinephrine secretion (GO:0010700) | 2.48776996 |
| 52 | proline transport (GO:0015824) | 2.48765172 |
| 53 | mesodermal cell differentiation (GO:0048333) | 2.47597070 |
| 54 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.47520973 |
| 55 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.45663741 |
| 56 | cell adhesion mediated by integrin (GO:0033627) | 2.45633937 |
| 57 | behavioral response to pain (GO:0048266) | 2.45602761 |
| 58 | embryonic eye morphogenesis (GO:0048048) | 2.45548250 |
| 59 | regulation of anoikis (GO:2000209) | 2.45526183 |
| 60 | axon extension involved in axon guidance (GO:0048846) | 2.45024476 |
| 61 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.45024476 |
| 62 | cell migration involved in heart development (GO:0060973) | 2.43417697 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 2.42302977 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41770312 |
| 65 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.40351991 |
| 66 | regulation of monocyte chemotaxis (GO:0090025) | 2.39536913 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39058846 |
| 68 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.38469949 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.37964283 |
| 70 | response to host immune response (GO:0052572) | 2.37964283 |
| 71 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.35847391 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.35027433 |
| 73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.34955765 |
| 74 | neutrophil mediated immunity (GO:0002446) | 2.34117746 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 2.33783291 |
| 76 | granulocyte activation (GO:0036230) | 2.33180891 |
| 77 | mammary gland epithelial cell proliferation (GO:0033598) | 2.32021784 |
| 78 | germinal center formation (GO:0002467) | 2.31330718 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 2.31328180 |
| 80 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.31146832 |
| 81 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.31041096 |
| 82 | regulation of platelet aggregation (GO:0090330) | 2.30945212 |
| 83 | positive regulation of extracellular matrix organization (GO:1903055) | 2.29383721 |
| 84 | membrane raft organization (GO:0031579) | 2.28579674 |
| 85 | regulation of synaptic vesicle transport (GO:1902803) | 2.28433639 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.28210794 |
| 87 | response to host (GO:0075136) | 2.28210794 |
| 88 | response to host defenses (GO:0052200) | 2.28210794 |
| 89 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27741095 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.27467783 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 2.27017790 |
| 92 | locomotory exploration behavior (GO:0035641) | 2.26523600 |
| 93 | substrate-dependent cell migration (GO:0006929) | 2.26466331 |
| 94 | cortical cytoskeleton organization (GO:0030865) | 2.26214636 |
| 95 | chondrocyte proliferation (GO:0035988) | 2.25689830 |
| 96 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.25617072 |
| 97 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.24936972 |
| 98 | positive regulation of leukocyte degranulation (GO:0043302) | 2.24557737 |
| 99 | wound healing, spreading of cells (GO:0044319) | 2.24058199 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.23025487 |
| 101 | myelin assembly (GO:0032288) | 2.22968439 |
| 102 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.22695468 |
| 103 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.20672014 |
| 104 | negative regulation of actin filament polymerization (GO:0030837) | 2.20382221 |
| 105 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.19985480 |
| 106 | cell migration in hindbrain (GO:0021535) | 2.18725302 |
| 107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.18076302 |
| 108 | macroautophagy (GO:0016236) | 2.18032312 |
| 109 | response to laminar fluid shear stress (GO:0034616) | 2.17910915 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 2.17782831 |
| 111 | natural killer cell differentiation (GO:0001779) | 2.17281740 |
| 112 | apoptotic cell clearance (GO:0043277) | 2.16736601 |
| 113 | cortical actin cytoskeleton organization (GO:0030866) | 2.16478626 |
| 114 | neutrophil activation (GO:0042119) | 2.15123609 |
| 115 | negative regulation of glial cell proliferation (GO:0060253) | 2.15010302 |
| 116 | myeloid cell activation involved in immune response (GO:0002275) | 2.14844147 |
| 117 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.14788352 |
| 118 | respiratory burst (GO:0045730) | 2.14691258 |
| 119 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.14545055 |
| 120 | SMAD protein complex assembly (GO:0007183) | 2.14543735 |
| 121 | cellular response to vitamin D (GO:0071305) | 2.13948290 |
| 122 | sodium ion export (GO:0071436) | 2.13942454 |
| 123 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.13661519 |
| 124 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.13661519 |
| 125 | regulation of protein heterodimerization activity (GO:0043497) | 2.13279683 |
| 126 | receptor catabolic process (GO:0032801) | 2.13095858 |
| 127 | macrophage activation (GO:0042116) | 2.11579774 |
| 128 | corticosteroid receptor signaling pathway (GO:0031958) | 2.11384835 |
| 129 | response to peptidoglycan (GO:0032494) | 2.11364757 |
| 130 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.11199545 |
| 131 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.11064654 |
| 132 | decidualization (GO:0046697) | 2.11056293 |
| 133 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.11046653 |
| 134 | artery development (GO:0060840) | 2.11012458 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.10973619 |
| 136 | sequestering of actin monomers (GO:0042989) | 2.10824302 |
| 137 | natural killer cell mediated immunity (GO:0002228) | 2.10738875 |
| 138 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.10738875 |
| 139 | actin filament capping (GO:0051693) | 2.10251443 |
| 140 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.09892133 |
| 141 | cellular response to virus (GO:0098586) | 2.09824692 |
| 142 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.09705217 |
| 143 | response to magnesium ion (GO:0032026) | 2.09649210 |
| 144 | regulation of ARF protein signal transduction (GO:0032012) | 2.09581278 |
| 145 | platelet aggregation (GO:0070527) | 2.09579197 |
| 146 | myeloid leukocyte mediated immunity (GO:0002444) | 2.09173392 |
| 147 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.09104881 |
| 148 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 2.08800781 |
| 149 | positive regulation of neuroblast proliferation (GO:0002052) | 2.08141069 |
| 150 | regulation of neuroblast proliferation (GO:1902692) | 2.08078484 |
| 151 | positive regulation of mast cell activation (GO:0033005) | 2.07979367 |
| 152 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.07857129 |
| 153 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.07370032 |
| 154 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.07370032 |
| 155 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.07370032 |
| 156 | collagen fibril organization (GO:0030199) | 2.07254169 |
| 157 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.06933719 |
| 158 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.06767061 |
| 159 | negative regulation of adherens junction organization (GO:1903392) | 2.06534270 |
| 160 | negative regulation of focal adhesion assembly (GO:0051895) | 2.06534270 |
| 161 | negative regulation of cell junction assembly (GO:1901889) | 2.06534270 |
| 162 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.05811364 |
| 163 | integrin-mediated signaling pathway (GO:0007229) | 2.05323150 |
| 164 | regulation of mast cell degranulation (GO:0043304) | 2.05298672 |
| 165 | regulation of leukocyte degranulation (GO:0043300) | 2.04702634 |
| 166 | chondrocyte development (GO:0002063) | 2.04301230 |
| 167 | regulation of macrophage cytokine production (GO:0010935) | 2.04252546 |
| 168 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.03880174 |
| 169 | myeloid dendritic cell differentiation (GO:0043011) | 2.03490202 |
| 170 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.03445583 |
| 171 | neuronal action potential propagation (GO:0019227) | 2.02464441 |
| 172 | regulation of platelet activation (GO:0010543) | 2.01973906 |
| 173 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.00812616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.48963945 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.08506652 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03264535 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.95074468 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94607482 |
| 6 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78690501 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21340663 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21336187 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16035549 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14197640 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.10849801 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10136720 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98510165 |
| 14 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87966897 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84754310 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79642242 |
| 17 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.78269170 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76052945 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75017147 |
| 20 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.74829250 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74810426 |
| 22 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.74601121 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73416148 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63943109 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.62708789 |
| 26 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.59031675 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.59000829 |
| 28 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55768289 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54842215 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54209134 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52351452 |
| 32 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.51038572 |
| 33 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.51038572 |
| 34 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.50887219 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50280747 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50133421 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49404744 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49404744 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49051874 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.48786225 |
| 41 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48332430 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47038684 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46186376 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44289878 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41441591 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38823698 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38417634 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36515455 |
| 49 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35607241 |
| 50 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.35071411 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34149298 |
| 52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31936836 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31682665 |
| 54 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29390255 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28272689 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28117209 |
| 57 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27957938 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27938797 |
| 59 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27286664 |
| 60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27148901 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26962437 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26831502 |
| 63 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.26385922 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26333319 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26316997 |
| 66 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26124170 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26062702 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25154835 |
| 69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24888175 |
| 70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23121783 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22729909 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22217205 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22076249 |
| 74 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.21822284 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21309207 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20316064 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20279445 |
| 78 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.19806077 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19191024 |
| 80 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.19127170 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18648598 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18318368 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17795845 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17516177 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16865780 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15949213 |
| 87 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14513675 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 1.13777698 |
| 89 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13586733 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13497984 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.12367906 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12045700 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10782101 |
| 94 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10755008 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10071622 |
| 96 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.09294978 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09293837 |
| 98 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08750045 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07953280 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07375157 |
| 101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06790480 |
| 102 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05772173 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05050989 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.04785784 |
| 105 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04679917 |
| 106 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04545090 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04524413 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04480933 |
| 109 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03763381 |
| 110 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02757637 |
| 111 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.02307594 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01956369 |
| 113 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01606944 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01435585 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01398758 |
| 116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00545332 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00049117 |
| 118 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99283736 |
| 119 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99282345 |
| 120 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98312662 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97870400 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97397533 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95984447 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95803081 |
| 125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95346027 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95191944 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95191944 |
| 128 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95018718 |
| 129 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94956113 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94214739 |
| 131 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94114203 |
| 132 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94002967 |
| 133 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93297181 |
| 134 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93093576 |
| 135 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93093576 |
| 136 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92902381 |
| 137 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92001621 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91911889 |
| 139 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91797091 |
| 140 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91760432 |
| 141 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87910878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.54646519 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.50235581 |
| 3 | MP0003303_peritoneal_inflammation | 2.87605745 |
| 4 | MP0004510_myositis | 2.71374886 |
| 5 | MP0002735_abnormal_chemical_nociception | 2.66953499 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.59569821 |
| 7 | MP0006054_spinal_hemorrhage | 2.47138306 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.41808171 |
| 9 | MP0002736_abnormal_nociception_after | 2.19113290 |
| 10 | MP0005623_abnormal_meninges_morphology | 2.06414816 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.05283700 |
| 12 | MP0003724_increased_susceptibility_to | 2.03338505 |
| 13 | MP0001348_abnormal_lacrimal_gland | 1.99913569 |
| 14 | MP0003950_abnormal_plasma_membrane | 1.96029333 |
| 15 | MP0003091_abnormal_cell_migration | 1.92015952 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 1.81373125 |
| 17 | MP0004858_abnormal_nervous_system | 1.81239331 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.80038872 |
| 19 | MP0003183_abnormal_peptide_metabolism | 1.73434166 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.71180461 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.71180461 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.68928834 |
| 23 | MP0008004_abnormal_stomach_pH | 1.68149234 |
| 24 | MP0004270_analgesia | 1.68137349 |
| 25 | MP0005451_abnormal_body_composition | 1.66219545 |
| 26 | MP0001958_emphysema | 1.64777090 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.62768759 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.61494930 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.59281587 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.58290220 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.56077034 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.55410162 |
| 33 | MP0003436_decreased_susceptibility_to | 1.54332151 |
| 34 | MP0003045_fibrosis | 1.52308815 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.52224210 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.51733616 |
| 37 | MP0002419_abnormal_innate_immunity | 1.51334786 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.51154369 |
| 39 | MP0009278_abnormal_bone_marrow | 1.50165672 |
| 40 | MP0003279_aneurysm | 1.49883852 |
| 41 | MP0003880_abnormal_central_pattern | 1.47653390 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.45788512 |
| 43 | MP0001915_intracranial_hemorrhage | 1.42835711 |
| 44 | MP0005164_abnormal_response_to | 1.41671075 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.40416906 |
| 46 | MP0000685_abnormal_immune_system | 1.39203467 |
| 47 | MP0001970_abnormal_pain_threshold | 1.38136021 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.34864267 |
| 49 | MP0005409_darkened_coat_color | 1.34267827 |
| 50 | MP0000428_abnormal_craniofacial_morphol | 1.30900255 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.30178670 |
| 52 | MP0000343_altered_response_to | 1.30003233 |
| 53 | MP0004272_abnormal_basement_membrane | 1.29468311 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.28748373 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.28612786 |
| 56 | MP0005503_abnormal_tendon_morphology | 1.27187615 |
| 57 | MP0009046_muscle_twitch | 1.25918101 |
| 58 | MP0005671_abnormal_response_to | 1.21488971 |
| 59 | MP0001542_abnormal_bone_strength | 1.21227672 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.20113686 |
| 61 | MP0004811_abnormal_neuron_physiology | 1.17802423 |
| 62 | MP0005387_immune_system_phenotype | 1.17683028 |
| 63 | MP0001790_abnormal_immune_system | 1.17683028 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.16240563 |
| 65 | MP0001819_abnormal_immune_cell | 1.15038938 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.13745179 |
| 67 | MP0000858_altered_metastatic_potential | 1.13236827 |
| 68 | MP0009785_altered_susceptibility_to | 1.11797168 |
| 69 | MP0002398_abnormal_bone_marrow | 1.11111574 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.10877768 |
| 71 | MP0002060_abnormal_skin_morphology | 1.10666990 |
| 72 | MP0002723_abnormal_immune_serum | 1.10349100 |
| 73 | MP0002163_abnormal_gland_morphology | 1.10234489 |
| 74 | MP0001800_abnormal_humoral_immune | 1.08669328 |
| 75 | MP0002896_abnormal_bone_mineralization | 1.07445423 |
| 76 | MP0000613_abnormal_salivary_gland | 1.06834475 |
| 77 | MP0002006_tumorigenesis | 1.06523638 |
| 78 | MP0002063_abnormal_learning/memory/cond | 1.05668200 |
| 79 | MP0008260_abnormal_autophagy | 1.05643649 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.04163542 |
| 81 | MP0003448_altered_tumor_morphology | 1.03453765 |
| 82 | MP0002064_seizures | 1.03020165 |
| 83 | MP0010307_abnormal_tumor_latency | 1.00896427 |
| 84 | MP0001299_abnormal_eye_distance/ | 1.00429902 |
| 85 | MP0000733_abnormal_muscle_development | 1.00356594 |
| 86 | MP0002396_abnormal_hematopoietic_system | 1.00013575 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.97192583 |
| 88 | MP0001853_heart_inflammation | 0.97160672 |
| 89 | MP0005275_abnormal_skin_tensile | 0.96256936 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.96235052 |
| 91 | MP0003941_abnormal_skin_development | 0.95858127 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.95838460 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.93427243 |
| 94 | MP0005025_abnormal_response_to | 0.93144088 |
| 95 | MP0006082_CNS_inflammation | 0.90446534 |
| 96 | MP0001849_ear_inflammation | 0.87942044 |
| 97 | MP0002295_abnormal_pulmonary_circulatio | 0.87848130 |
| 98 | MP0004947_skin_inflammation | 0.87324712 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.86865076 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.86620572 |
| 101 | MP0003795_abnormal_bone_structure | 0.86217652 |
| 102 | MP0003385_abnormal_body_wall | 0.86005569 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.84656286 |
| 104 | MP0005595_abnormal_vascular_smooth | 0.84533275 |
| 105 | MP0002405_respiratory_system_inflammati | 0.82450025 |
| 106 | MP0002184_abnormal_innervation | 0.82434315 |
| 107 | MP0000716_abnormal_immune_system | 0.82176131 |
| 108 | MP0006138_congestive_heart_failure | 0.80997424 |
| 109 | MP0000534_abnormal_ureter_morphology | 0.80577857 |
| 110 | MP0001614_abnormal_blood_vessel | 0.79615958 |
| 111 | MP0009745_abnormal_behavioral_response | 0.79460831 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.79281772 |
| 113 | MP0005390_skeleton_phenotype | 0.79039405 |
| 114 | MP0002925_abnormal_cardiovascular_devel | 0.77511671 |
| 115 | MP0000371_diluted_coat_color | 0.77170370 |
| 116 | MP0000249_abnormal_blood_vessel | 0.77035270 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.76700569 |
| 118 | MP0001243_abnormal_dermal_layer | 0.75466473 |
| 119 | MP0004233_abnormal_muscle_weight | 0.74984869 |
| 120 | MP0003075_altered_response_to | 0.74529802 |
| 121 | MP0005197_abnormal_uvea_morphology | 0.74472810 |
| 122 | MP0001175_abnormal_lung_morphology | 0.73971344 |
| 123 | MP0001851_eye_inflammation | 0.73127372 |
| 124 | MP0005310_abnormal_salivary_gland | 0.72839458 |
| 125 | MP0003942_abnormal_urinary_system | 0.71858725 |
| 126 | MP0009780_abnormal_chondrocyte_physiolo | 0.71142600 |
| 127 | MP0002168_other_aberrant_phenotype | 0.71043020 |
| 128 | MP0000689_abnormal_spleen_morphology | 0.70778810 |
| 129 | MP0002113_abnormal_skeleton_development | 0.70745725 |
| 130 | MP0005621_abnormal_cell_physiology | 0.70257714 |
| 131 | MP0002429_abnormal_blood_cell | 0.69539971 |
| 132 | MP0004134_abnormal_chest_morphology | 0.69151216 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.68769053 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.68131925 |
| 135 | MP0005023_abnormal_wound_healing | 0.67768959 |
| 136 | MP0005058_abnormal_lysosome_morphology | 0.67506237 |
| 137 | MP0003690_abnormal_glial_cell | 0.66768512 |
| 138 | MP0002572_abnormal_emotion/affect_behav | 0.66643887 |
| 139 | MP0003828_pulmonary_edema | 0.66282294 |
| 140 | MP0002177_abnormal_outer_ear | 0.65908992 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.65229098 |
| 142 | MP0009764_decreased_sensitivity_to | 0.64700256 |
| 143 | MP0008569_lethality_at_weaning | 0.64251281 |
| 144 | MP0004883_abnormal_blood_vessel | 0.63745408 |
| 145 | MP0002722_abnormal_immune_system | 0.63477235 |
| 146 | MP0000604_amyloidosis | 0.61935655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal gallbladder physiology (HP:0012438) | 3.84729971 |
| 2 | Cholecystitis (HP:0001082) | 3.84729971 |
| 3 | Peripheral hypomyelination (HP:0007182) | 3.79095167 |
| 4 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.67284481 |
| 5 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.33081776 |
| 6 | Spondylolisthesis (HP:0003302) | 3.26384197 |
| 7 | Arterial tortuosity (HP:0005116) | 3.25699763 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.25278312 |
| 9 | Vascular tortuosity (HP:0004948) | 3.24156603 |
| 10 | Submucous cleft hard palate (HP:0000176) | 3.12062838 |
| 11 | Morphological abnormality of the middle ear (HP:0008609) | 3.06717075 |
| 12 | Recurrent abscess formation (HP:0002722) | 2.84369060 |
| 13 | Difficulty running (HP:0009046) | 2.81290618 |
| 14 | Thoracolumbar scoliosis (HP:0002944) | 2.80095069 |
| 15 | Osteolytic defects of the hand bones (HP:0009699) | 2.69519417 |
| 16 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.69519417 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.65786025 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 2.65786025 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.65786025 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.65585709 |
| 21 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.62554912 |
| 22 | Hypoplasia of the fovea (HP:0007750) | 2.62554912 |
| 23 | Midline defect of the nose (HP:0004122) | 2.57265130 |
| 24 | Increased mean platelet volume (HP:0011877) | 2.57087944 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 2.53739010 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.51376412 |
| 27 | Abnormal platelet volume (HP:0011876) | 2.51233324 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.50268636 |
| 29 | J-shaped sella turcica (HP:0002680) | 2.49524203 |
| 30 | Follicular hyperkeratosis (HP:0007502) | 2.49011515 |
| 31 | Dilatation of the ascending aorta (HP:0005111) | 2.45911869 |
| 32 | Congenital glaucoma (HP:0001087) | 2.45349025 |
| 33 | Reticulocytosis (HP:0001923) | 2.44758344 |
| 34 | Peritonitis (HP:0002586) | 2.44340223 |
| 35 | Myocardial infarction (HP:0001658) | 2.41491489 |
| 36 | Overgrowth (HP:0001548) | 2.40627061 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.36874517 |
| 38 | Absent eyebrow (HP:0002223) | 2.36426179 |
| 39 | Premature rupture of membranes (HP:0001788) | 2.33867550 |
| 40 | Broad face (HP:0000283) | 2.27691555 |
| 41 | Wormian bones (HP:0002645) | 2.27341749 |
| 42 | Absent frontal sinuses (HP:0002688) | 2.27212079 |
| 43 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.26716470 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.24520406 |
| 45 | Syringomyelia (HP:0003396) | 2.21216477 |
| 46 | Spinal cord lesions (HP:0100561) | 2.21216477 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.17965915 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.16827643 |
| 49 | Focal seizures (HP:0007359) | 2.16326748 |
| 50 | Absent eyelashes (HP:0000561) | 2.12262860 |
| 51 | Cutaneous finger syndactyly (HP:0010554) | 2.11998505 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.11604084 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11604084 |
| 54 | Genu recurvatum (HP:0002816) | 2.09892262 |
| 55 | Camptodactyly of toe (HP:0001836) | 2.08987998 |
| 56 | Deformed sella turcica (HP:0002681) | 2.08406780 |
| 57 | Chin dimple (HP:0010751) | 2.08305638 |
| 58 | Menorrhagia (HP:0000132) | 2.07826778 |
| 59 | Aneurysm (HP:0002617) | 2.06825025 |
| 60 | Shallow orbits (HP:0000586) | 2.06646457 |
| 61 | Fragile skin (HP:0001030) | 2.06346783 |
| 62 | Febrile seizures (HP:0002373) | 2.06198216 |
| 63 | Bilateral microphthalmos (HP:0007633) | 2.05015309 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04522634 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04522634 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04522634 |
| 67 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.03063963 |
| 68 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.01144837 |
| 69 | Overlapping toe (HP:0001845) | 2.00315037 |
| 70 | Spinal rigidity (HP:0003306) | 2.00282415 |
| 71 | Atrophic scars (HP:0001075) | 1.98995765 |
| 72 | Action tremor (HP:0002345) | 1.98365318 |
| 73 | Papilledema (HP:0001085) | 1.97544394 |
| 74 | Joint laxity (HP:0001388) | 1.95778832 |
| 75 | Achilles tendon contracture (HP:0001771) | 1.95737442 |
| 76 | Soft skin (HP:0000977) | 1.95114295 |
| 77 | Myokymia (HP:0002411) | 1.95056455 |
| 78 | Prolonged bleeding time (HP:0003010) | 1.92470562 |
| 79 | Polycythemia (HP:0001901) | 1.91888156 |
| 80 | Abnormality of the fovea (HP:0000493) | 1.89742710 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 1.89176578 |
| 82 | Tibial bowing (HP:0002982) | 1.88857094 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 1.88555323 |
| 84 | Hip contracture (HP:0003273) | 1.88369776 |
| 85 | Myositis (HP:0100614) | 1.88088418 |
| 86 | Distal arthrogryposis (HP:0005684) | 1.87591729 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 1.87460788 |
| 88 | Gingival bleeding (HP:0000225) | 1.87357533 |
| 89 | Papillary thyroid carcinoma (HP:0002895) | 1.87338625 |
| 90 | Narrow palate (HP:0000189) | 1.87116442 |
| 91 | Hematochezia (HP:0002573) | 1.86737491 |
| 92 | Atonic seizures (HP:0010819) | 1.86541940 |
| 93 | Thin bony cortex (HP:0002753) | 1.85886812 |
| 94 | Increased density of long bones (HP:0006392) | 1.85121429 |
| 95 | Increased connective tissue (HP:0009025) | 1.85033781 |
| 96 | Epileptic encephalopathy (HP:0200134) | 1.84210589 |
| 97 | Obstructive sleep apnea (HP:0002870) | 1.84181523 |
| 98 | Mask-like facies (HP:0000298) | 1.84086815 |
| 99 | Disproportionate tall stature (HP:0001519) | 1.83681505 |
| 100 | Flared iliac wings (HP:0002869) | 1.83474786 |
| 101 | Blue sclerae (HP:0000592) | 1.82579755 |
| 102 | Striae distensae (HP:0001065) | 1.82111550 |
| 103 | Orchitis (HP:0100796) | 1.81835802 |
| 104 | Disinhibition (HP:0000734) | 1.81573217 |
| 105 | Bowel diverticulosis (HP:0005222) | 1.81572594 |
| 106 | Optic neuritis (HP:0100653) | 1.81397515 |
| 107 | Retrobulbar optic neuritis (HP:0100654) | 1.81397515 |
| 108 | Ankle contracture (HP:0006466) | 1.80588130 |
| 109 | Mitral valve prolapse (HP:0001634) | 1.80541112 |
| 110 | Hypercortisolism (HP:0001578) | 1.79133023 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 1.79090515 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.78507655 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 1.78175862 |
| 114 | Absent phalangeal crease (HP:0006109) | 1.77725273 |
| 115 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.77366801 |
| 116 | Obstructive lung disease (HP:0006536) | 1.77194574 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77194574 |
| 118 | Inappropriate behavior (HP:0000719) | 1.76770812 |
| 119 | Lower limb amyotrophy (HP:0007210) | 1.76643310 |
| 120 | Knee flexion contracture (HP:0006380) | 1.76455842 |
| 121 | Slender build (HP:0001533) | 1.76348439 |
| 122 | Short nail (HP:0001799) | 1.76073266 |
| 123 | Decreased motor nerve conduction velocity (HP:0003431) | 1.76040363 |
| 124 | Wrist flexion contracture (HP:0001239) | 1.76026030 |
| 125 | Aortic aneurysm (HP:0004942) | 1.75911180 |
| 126 | Cellulitis (HP:0100658) | 1.75259787 |
| 127 | Mitral regurgitation (HP:0001653) | 1.74586917 |
| 128 | Mitral stenosis (HP:0001718) | 1.74437234 |
| 129 | Aortic dissection (HP:0002647) | 1.74134751 |
| 130 | Flexion contracture of toe (HP:0005830) | 1.73803220 |
| 131 | Joint contractures involving the joints of the feet (HP:0100492) | 1.73803220 |
| 132 | Asymmetry of the thorax (HP:0001555) | 1.73554110 |
| 133 | Abnormality of the frontal sinuses (HP:0002687) | 1.72426247 |
| 134 | Nuclear cataract (HP:0100018) | 1.71979266 |
| 135 | Epistaxis (HP:0000421) | 1.71862449 |
| 136 | Apathy (HP:0000741) | 1.71781577 |
| 137 | Cholelithiasis (HP:0001081) | 1.71671746 |
| 138 | Global brain atrophy (HP:0002283) | 1.71177178 |
| 139 | Relative macrocephaly (HP:0004482) | 1.70320410 |
| 140 | Vertebral arch anomaly (HP:0008438) | 1.69277821 |
| 141 | Focal motor seizures (HP:0011153) | 1.69032112 |
| 142 | Bruising susceptibility (HP:0000978) | 1.68413711 |
| 143 | Ulnar claw (HP:0001178) | 1.68331028 |
| 144 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.68069381 |
| 145 | Cerebral inclusion bodies (HP:0100314) | 1.67642310 |
| 146 | Cervical subluxation (HP:0003308) | 1.67405093 |
| 147 | Broad palm (HP:0001169) | 1.66462327 |
| 148 | Diminished motivation (HP:0000745) | 1.66257505 |
| 149 | Protuberant abdomen (HP:0001538) | 1.65483905 |
| 150 | Increased variability in muscle fiber diameter (HP:0003557) | 1.65478466 |
| 151 | Spinal canal stenosis (HP:0003416) | 1.64464689 |
| 152 | Neonatal short-limb short stature (HP:0008921) | 1.64158102 |
| 153 | Gingivitis (HP:0000230) | 1.64094572 |
| 154 | Esophageal varix (HP:0002040) | 1.63492285 |
| 155 | Abnormality of the pubic bones (HP:0003172) | 1.63048139 |
| 156 | Hypoventilation (HP:0002791) | 1.62943289 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.62801229 |
| 158 | Down-sloping shoulders (HP:0200021) | 1.62619947 |
| 159 | Upper limb amyotrophy (HP:0009129) | 1.61965013 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.61965013 |
| 161 | Failure to thrive in infancy (HP:0001531) | 1.60930358 |
| 162 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.60628988 |
| 163 | Autoimmune thrombocytopenia (HP:0001973) | 1.59906844 |
| 164 | Arterial thrombosis (HP:0004420) | 1.58490511 |
| 165 | Bladder diverticulum (HP:0000015) | 1.57636645 |
| 166 | Dysmetric saccades (HP:0000641) | 1.57521104 |
| 167 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.57274890 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.56990778 |
| 169 | Dislocated radial head (HP:0003083) | 1.56269099 |
| 170 | Cutaneous syndactyly (HP:0012725) | 1.56095311 |
| 171 | Macroorchidism (HP:0000053) | 1.56064680 |
| 172 | Acanthocytosis (HP:0001927) | 1.55711599 |
| 173 | Abnormal hair whorl (HP:0010721) | 1.54309920 |
| 174 | Long toe (HP:0010511) | 1.53434056 |
| 175 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.52682297 |
| 176 | Skull defect (HP:0001362) | 1.51263827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.33012042 |
| 2 | BLK | 3.20456432 |
| 3 | KSR2 | 3.12435718 |
| 4 | IRAK3 | 2.75224180 |
| 5 | TESK1 | 2.31674518 |
| 6 | MAP2K3 | 2.26685200 |
| 7 | TAOK3 | 2.24676485 |
| 8 | SIK2 | 2.19812927 |
| 9 | DAPK2 | 2.15225118 |
| 10 | TGFBR2 | 2.02841738 |
| 11 | TRIB3 | 1.98719336 |
| 12 | RET | 1.87828001 |
| 13 | MAP3K9 | 1.82323067 |
| 14 | HIPK2 | 1.81477433 |
| 15 | PLK2 | 1.74161005 |
| 16 | TESK2 | 1.71907392 |
| 17 | EPHB1 | 1.70631350 |
| 18 | GRK5 | 1.69577228 |
| 19 | PAK6 | 1.69354109 |
| 20 | FGR | 1.68107352 |
| 21 | MAP3K2 | 1.64421751 |
| 22 | LATS1 | 1.62836483 |
| 23 | MAP4K1 | 1.58398027 |
| 24 | LIMK1 | 1.58236660 |
| 25 | CSK | 1.57228441 |
| 26 | MAP3K3 | 1.53063039 |
| 27 | MET | 1.51531096 |
| 28 | MYLK | 1.51178336 |
| 29 | SCYL2 | 1.50870193 |
| 30 | MINK1 | 1.49770191 |
| 31 | PIM2 | 1.41054002 |
| 32 | NTRK3 | 1.39867050 |
| 33 | MAP3K14 | 1.38736737 |
| 34 | MAP3K6 | 1.37378003 |
| 35 | ICK | 1.35517806 |
| 36 | PRKD2 | 1.35000394 |
| 37 | IRAK2 | 1.32481088 |
| 38 | FES | 1.31276521 |
| 39 | CDK8 | 1.30839451 |
| 40 | AKT3 | 1.29757764 |
| 41 | PKN2 | 1.28688034 |
| 42 | STK38 | 1.27827059 |
| 43 | CAMKK1 | 1.27204919 |
| 44 | YES1 | 1.26063157 |
| 45 | DAPK1 | 1.25227607 |
| 46 | LATS2 | 1.21171259 |
| 47 | MAP3K4 | 1.19582209 |
| 48 | MAP3K13 | 1.15358309 |
| 49 | TTN | 1.15200527 |
| 50 | TAOK1 | 1.15174024 |
| 51 | JAK1 | 1.13073971 |
| 52 | NTRK1 | 1.11589415 |
| 53 | MARK2 | 1.11050251 |
| 54 | JAK3 | 1.09418561 |
| 55 | PRPF4B | 1.09216140 |
| 56 | KSR1 | 1.08658637 |
| 57 | SGK2 | 1.05882868 |
| 58 | SGK3 | 1.05762816 |
| 59 | MAP3K12 | 1.05568632 |
| 60 | PNCK | 1.05517297 |
| 61 | TBK1 | 1.04593315 |
| 62 | TLK1 | 1.03452249 |
| 63 | GRK7 | 1.02607848 |
| 64 | MAP2K7 | 1.02071348 |
| 65 | ERN1 | 1.01233189 |
| 66 | BMX | 0.98915921 |
| 67 | WNK1 | 0.98712306 |
| 68 | PRKD3 | 0.97273626 |
| 69 | RIPK1 | 0.96289312 |
| 70 | PDGFRA | 0.96235389 |
| 71 | DDR2 | 0.96000544 |
| 72 | PAK4 | 0.95544362 |
| 73 | MAP3K1 | 0.94767173 |
| 74 | DMPK | 0.91537067 |
| 75 | MAPK7 | 0.91525387 |
| 76 | PIK3CG | 0.91038443 |
| 77 | TAOK2 | 0.90624866 |
| 78 | FLT3 | 0.89468397 |
| 79 | CAMKK2 | 0.88250989 |
| 80 | MOS | 0.87732012 |
| 81 | HCK | 0.87335423 |
| 82 | EEF2K | 0.86795283 |
| 83 | TRPM7 | 0.86650558 |
| 84 | BMPR1B | 0.86421406 |
| 85 | MAP2K1 | 0.86178390 |
| 86 | SIK1 | 0.86001908 |
| 87 | ERBB4 | 0.85317876 |
| 88 | ZAP70 | 0.83307782 |
| 89 | CDK12 | 0.81448732 |
| 90 | IRAK4 | 0.79836338 |
| 91 | FGFR3 | 0.79349197 |
| 92 | MTOR | 0.78695215 |
| 93 | TYRO3 | 0.78643101 |
| 94 | SYK | 0.78463006 |
| 95 | JAK2 | 0.76640901 |
| 96 | CSF1R | 0.76547504 |
| 97 | RPS6KA2 | 0.76262074 |
| 98 | KIT | 0.75708669 |
| 99 | TYK2 | 0.75692922 |
| 100 | IKBKB | 0.73292325 |
| 101 | SIK3 | 0.72553743 |
| 102 | MAP2K4 | 0.72177033 |
| 103 | NEK9 | 0.71655776 |
| 104 | PDPK1 | 0.70402274 |
| 105 | LRRK2 | 0.69370426 |
| 106 | FRK | 0.68758944 |
| 107 | CCNB1 | 0.66859836 |
| 108 | CAMK1G | 0.66303145 |
| 109 | STK24 | 0.65040550 |
| 110 | ROCK1 | 0.64503684 |
| 111 | EPHA3 | 0.63757389 |
| 112 | MELK | 0.63285731 |
| 113 | CDK5 | 0.62542804 |
| 114 | BMPR2 | 0.62482785 |
| 115 | IRAK1 | 0.62359067 |
| 116 | GSK3A | 0.61697172 |
| 117 | DAPK3 | 0.58825861 |
| 118 | TGFBR1 | 0.58217255 |
| 119 | STK10 | 0.56075841 |
| 120 | CDK6 | 0.55955690 |
| 121 | CDK14 | 0.55585393 |
| 122 | PDK1 | 0.55377323 |
| 123 | CDC42BPA | 0.53427081 |
| 124 | EPHB2 | 0.51977704 |
| 125 | STK3 | 0.51552211 |
| 126 | RPS6KA4 | 0.51088732 |
| 127 | CDK18 | 0.50407978 |
| 128 | PRKCH | 0.50319919 |
| 129 | MATK | 0.50312375 |
| 130 | CAMK1D | 0.49808738 |
| 131 | CHUK | 0.49601115 |
| 132 | ALK | 0.49124189 |
| 133 | CDK15 | 0.48822006 |
| 134 | BRD4 | 0.47316948 |
| 135 | ROCK2 | 0.47243659 |
| 136 | PTK2 | 0.46803435 |
| 137 | CASK | 0.45538823 |
| 138 | RAF1 | 0.45184644 |
| 139 | PDGFRB | 0.44266141 |
| 140 | CDK9 | 0.42967834 |
| 141 | MAP3K5 | 0.42317557 |
| 142 | * PTK2B | 0.41500846 |
| 143 | RPS6KL1 | 0.41497634 |
| 144 | RPS6KC1 | 0.41497634 |
| 145 | ABL2 | 0.41341148 |
| 146 | PTK6 | 0.41269129 |
| 147 | PAK2 | 0.41264580 |
| 148 | MARK3 | 0.40742595 |
| 149 | SGK494 | 0.40355066 |
| 150 | SGK223 | 0.40355066 |
| 151 | STK38L | 0.38742920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.84635298 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99702415 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62551072 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59459056 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55531144 |
| 6 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42601147 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42210046 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.40719438 |
| 9 | Glioma_Homo sapiens_hsa05214 | 1.40614045 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34414245 |
| 11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30430325 |
| 12 | Salmonella infection_Homo sapiens_hsa05132 | 1.30375200 |
| 13 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27083355 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26678670 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.25614703 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25267697 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.25070367 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.24934841 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23823646 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23416880 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23289795 |
| 22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22633983 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22028576 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.20052777 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18546728 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17193688 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16386453 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15843873 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15306776 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15133788 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11229645 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09322950 |
| 33 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.08167754 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07789302 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.07230586 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06571067 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.05184658 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.04178553 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03392717 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03327115 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02389265 |
| 42 | Prostate cancer_Homo sapiens_hsa05215 | 1.01212693 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.99465455 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.98204914 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94288569 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93315550 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93123833 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.92448646 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92289557 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91941943 |
| 51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90993234 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89415362 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89372321 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89251388 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 0.88522138 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88136243 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87294328 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87213483 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87035761 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86706744 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.86434132 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.86161951 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.85665763 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85639283 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.85492231 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85414301 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84833388 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.84470080 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83946260 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83812337 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81795956 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81632985 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81609376 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81567919 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81533923 |
| 76 | * Endocytosis_Homo sapiens_hsa04144 | 0.81091232 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80871670 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80429994 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79873923 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79795156 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79228203 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78403291 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.77838642 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77491654 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76161328 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76040348 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75249570 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74952039 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74847916 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.74781742 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.74661024 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74608352 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74407586 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.73186908 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72286889 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70768240 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.70715069 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70407792 |
| 99 | Morphine addiction_Homo sapiens_hsa05032 | 0.70257412 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70145683 |
| 101 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69773796 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69117405 |
| 103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.69012126 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67362661 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.67112802 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67067988 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67038648 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66239637 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66193176 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65829334 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.65687097 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65287249 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.65082841 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65061834 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64731650 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64507626 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64185965 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.64027858 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63969533 |
| 120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63583059 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62820085 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.60815745 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60795297 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59985316 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58552948 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.56523920 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56210037 |

